This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

David Stack Biography and Net Worth

CEO of Pacira BioSciences

Mr. Stack has served as our Chief Executive Officer and as a director since November 2007, and as President from November 2007 to October 2015. In June 2013, Mr. Stack was appointed as the Chairman of our board of directors. Mr. Stack was Managing Director of MPM Capital, a private equity firm, from 2005 through March 2017 and has been a Managing Partner of Stack Pharmaceuticals, Inc., a commercialization, marketing, and strategy firm, since 1998. From 2001 to 2004, he was President and Chief Executive Officer of The Medicines Company (Nasdaq: MDCO). Previously, Mr. Stack was President and General Manager at Innovex, Inc. He was Vice President, Business Development/Marketing at Immunomedics from 1993 until 1995. Prior to that, he was with Roche Laboratories in positions of increasing responsibility from 1981 until 1993, including Therapeutic World Leader in Infectious Disease and Director, Business Development and Planning, Infectious Disease, Oncology, and Virology. He currently serves as a member of the board of directors of Prognos AI, Chiasma, Inc. (Nasdaq: CHMA) and Amarin Corporation plc (Nasdaq: AMRN). He was a member of the boards of directors of Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) from 2006 to 2010 and BioClinica, Inc. (Nasdaq: BIOC) from 1999 to 2010. Mr. Stack holds a B.S. in pharmacy from Albany College of Pharmacy and a B.S. in Biology from Siena College.

What is David M. Stack's net worth?: The estimated net worth of David M. Stack is at least $4.06 million as of June 6th, 2023. Mr. Stack owns 159,107 shares of Pacira BioSciences stock worth more than $4,057,229 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. Stack may own. Additionally, Mr. Stack receives a salary of $1,540,000.00 as CEO at Pacira BioSciences. Learn More about David M. Stack's net worth.
How old is David M. Stack?: Mr. Stack is currently 74 years old. There are 7 older executives and no younger executives at Pacira BioSciences. Learn More on David M. Stack's age.
What is David M. Stack's salary?: As the CEO of Pacira BioSciences, Inc., Mr. Stack earns $1,540,000.00 per year. Learn More on David M. Stack's salary.
How do I contact David M. Stack?: The corporate mailing address for Mr. Stack and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on David M. Stack's contact information.
Has David M. Stack been buying or selling shares of Pacira BioSciences?: David M. Stack has not been actively trading shares of Pacira BioSciences during the last quarter. Most recently, David M. Stack sold 5,058 shares of the business's stock in a transaction on Tuesday, June 6th. The shares were sold at an average price of $38.99, for a transaction totalling $197,211.42. Following the completion of the sale, the chief executive officer now directly owns 159,107 shares of the company's stock, valued at $6,203,581.93. Learn More on David M. Stack's trading history.
Who are Pacira BioSciences' active insiders?: Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.
Are insiders buying or selling shares of Pacira BioSciences?: In the last twelve months, insiders at the sold shares 16 times. They sold a total of 138,857 shares worth more than $4,613,719.15. The most recent insider tranaction occured on March, 8th when Director Gary W Pace sold 90,000 shares worth more than $2,754,000.00. Insiders at Pacira BioSciences own 6.6% of the company. Learn More about insider trades at Pacira BioSciences.
Information on this page was last updated on 3/8/2024.

David M. Stack Insider Trading History at Pacira BioSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/6/2023	Sell	5,058	$38.99	$197,211.42	159,107
6/8/2022	Sell	13,828	$59.85	$827,605.80	142,251
6/6/2022	Sell	11,965	$61.37	$734,292.05	156,079
6/4/2021	Sell	14,905	$61.04	$909,801.20	61,156
5/11/2021	Sell	21,250	$60.93	$1,294,762.50	97,311
2/3/2021	Sell	21,250	$71.21	$1,513,212.50
10/15/2020	Sell	30,000	$55.00	$1,650,000.00	203,377
7/15/2020	Sell	12,000	$56.88	$682,560.00
6/8/2020	Sell	17,111	$48.12	$823,381.32	184,020
6/4/2020	Sell	14,314	$46.33	$663,167.62	184,020
1/15/2020	Sell	25,000	$42.68	$1,067,000.00
11/15/2019	Sell	70,000	$44.47	$3,112,900.00
8/15/2019	Sell	12,849	$39.15	$503,038.35
7/8/2019	Sell	13,115	$42.88	$562,371.20
6/4/2019	Sell	12,385	$42.91	$531,440.35
11/15/2018	Sell	15,000	$47.39	$710,850.00
8/15/2018	Sell	33,062	$47.32	$1,564,493.84
6/7/2018	Sell	18,406	$36.28	$667,769.68	91,831
5/15/2018	Sell	25,000	$33.79	$844,750.00	115,446
1/10/2018	Sell	28,885	$40.19	$1,160,888.15
11/15/2017	Sell	58,885	$38.34	$2,257,650.90	159,164
8/15/2017	Sell	28,885	$36.37	$1,050,547.45	159,164
6/5/2017	Sell	4,311	$43.32	$186,752.52	59,559
1/17/2017	Sell	15,000	$38.41	$576,150.00
8/15/2016	Sell	15,000	$45.32	$679,800.00
4/15/2016	Sell	25,000	$64.14	$1,603,500.00	25,285
1/15/2016	Sell	15,000	$63.84	$957,600.00	285
10/15/2015	Sell	15,000	$37.57	$563,550.00	176
7/15/2015	Sell	15,000	$67.78	$1,016,700.00
4/15/2015	Sell	25,000	$90.50	$2,262,500.00
1/15/2015	Sell	15,000	$97.52	$1,462,800.00
7/15/2014	Sell	15,000	$86.75	$1,301,250.00
6/28/2013	Sell	15,000	$28.73	$430,950.00

David M. Stack Buying and Selling Activity at Pacira BioSciences

Pacira BioSciences Company Overview

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Today's Range

Now: $25.50

$25.33

$26.00

50 Day Range

MA: $28.76

$25.50

$31.41

2 Week Range

Now: $25.50

$25.33

$48.60

Volume

305,832 shs

Average Volume

492,049 shs

Market Capitalization

$1.19 billion

P/E Ratio

31.48

Dividend Yield

N/A

Beta

0.76

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

David Stack Biography and Net Worth

What is David M. Stack's net worth?

How old is David M. Stack?

What is David M. Stack's salary?

How do I contact David M. Stack?

Has David M. Stack been buying or selling shares of Pacira BioSciences?

Who are Pacira BioSciences' active insiders?

Are insiders buying or selling shares of Pacira BioSciences?